Chargement en cours...
A Comparative Pharmacokinetics Study of the Anti-Parkinsonian Drug Pramipexole
The present study aimed to compare pharmacokinetic parameters of two pramipexole 0.25 mg formulations in order to show bioequivalence. The study was conducted in a randomized, open-label, two-period, two-sequence, and crossover design, involving 23 healthy volunteers. One of the 0.25 mg formulations...
Enregistré dans:
| Publié dans: | Sci Pharm |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5198030/ https://ncbi.nlm.nih.gov/pubmed/27869754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/scipharm84040715 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|